Atlas Trials

Evaluation of Trastuzumab In Patients With HER2 Positive Persistent Or Recurrent Vulvar Paget's Disease

Clinical trial NCT01427244 · WITHDRAWN

Trial details

NCT number
NCT01427244
Sponsor
Yale University
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Paget's Disease of the Vulva
Start date
2011-08-01
Primary completion
2014-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.